Kymera Therapeutics, Inc. Logo

Kymera Therapeutics, Inc.

Fintech firm providing data analytics and market intelligence for investment professionals.

KYMR | NDAQ

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
United States of America
Address:
500 NORTH BEACON STREET, 4TH FLOOR, 2472 WATERTOWN
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Kymera Therapeutics, Inc. is a revolutionary financial technology firm redefining investment paradigms through targeted data analytics. Leveraging its powerful and highly productive data discovery engine, the company delivers a pipeline of first-in-class analytics and market intelligence solutions for financial institutions and investment professionals. Kymera's platform provides a market-agnostic modality for discovering alpha and managing risk, fundamentally changing how clients access and utilize data. The firm is committed to delivering transformative insights with precision, focus, and a sense of urgency to a global client base.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-04 13:15
Quarterly Report
10-Q - Kymera Therapeutics, Inc. (0001815442) (Filer)
English 2.2 MB
2025-11-04 13:10
Regulatory News Service
8-K - Kymera Therapeutics, Inc. (0001815442) (Filer)
English 225.9 KB

Automate Your Workflow. Get a real-time feed of all Kymera Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Kymera Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Kymera Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Acrivon Therapeutics, Inc. Logo
Develops precision cancer therapies by matching patients to drugs using its proteomics platform.
United States of America ACRV
Acticor Biotech Logo
Clinical-stage biopharma developing a first-in-class drug for thrombotic diseases like stroke.
France ALACT
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing an antibody therapy for Alzheimer's by targeting toxic AβOs.
United States of America ABOS
Adaptive Biotechnologies Corp Logo
Maps immune genetics for blood cancer diagnostics and drug discovery partnerships.
United States of America ADPT
Adecco Group AG Logo
Global talent solutions firm offering staffing, placement, career transition, and tech consulting.
Switzerland ADI1
Adeia Inc. Logo
Invents and licenses foundational IP for the media and semiconductor industries.
United States of America ADEA
ADforus Co., Ltd. Logo
Ad-tech firm with AI platforms for mobile marketing and publisher monetization solutions.
South Korea 397810
Aditxt, Inc. Logo
Acquires and develops biotech for autoimmunity, cancer detection, and neuro diagnostics.
United States of America ADTX
Adocia Logo
Biotech improving protein drug formulations for diabetes & obesity and developing cell therapies.
France ADOC
ad pepper media International N.V. Logo
Global performance marketing & audience targeting solutions for advertisers and agencies worldwide.
Germany APM

Talk to a Data Expert

Have a question? We'll get back to you promptly.